纵隔恶性生殖细胞肿瘤临床、影像及病理特点的相关研究

注册号:

Registration number:

ChiCTR1900026756 

最近更新日期:

Date of Last Refreshed on:

2019-10-20 22:10:54 

注册时间:

Date of Registration:

2019-10-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

纵隔恶性生殖细胞肿瘤临床、影像及病理特点的相关研究

Public title:

Study for clinical, radiological and pathological features of primary mediastinal germ cell tumors

注册题目简写:

English Acronym:

研究课题的正式科学名称:

纵隔恶性生殖细胞肿瘤临床、影像及病理特点的相关研究

Scientific title:

Study for clinical, radiological and pathological features of primary mediastinal germ cell tumors

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

章雪飞 

研究负责人:

章雪飞 

Applicant:

Xuefei Zhang 

Study leader:

Xuefei Zhang 

申请注册联系人电话:

Applicant telephone:

+86 18801902167

研究负责人电话:

Study leader's
telephone:

+86 18801902167

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

docchang@126.com

研究负责人电子邮件:

Study leader's E-mail:

docchang@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区淮海西路241号

研究负责人通讯地址:

上海市徐汇区淮海西路241号

Applicant address:

241 Huaihai Road West, Shanghai, China

Study leader's address:

241 Huaihai Road West, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市胸科医院

Applicant's institution:

Shanghai Chest Hospital, Shanghai Jiaotong University

研究负责人所在单位:

上海市胸科医院

Affiliation of the Leader:

Shanghai Chest Hospital, Shanghai Jiaotong University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KS1966

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市胸科医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Chest Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2019-09-20 00:00:00

伦理委员会联系人:

陈仲林

Contact Name of the ethic committee:

Zhonglin Chen

伦理委员会联系地址:

上海市徐汇区淮海西路241号

Contact Address of the ethic committee:

241 Huaihai Road West, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市胸科医院

Primary sponsor:

Shanghai Chest Hospital, Shanghai Jiaotong University

研究实施负责(组长)单位地址:

上海市徐汇区淮海西路241号

Primary sponsor's address:

241 Huaihai Road West, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市胸科医院

具体地址:

徐汇区淮海西路241号

Institution
hospital:

Shanghai Chest Hospital, Shanghai Jiaotong University

Address:

241 Huaihai Road West, Xuhui District

经费或物资来源:

上海市胸科医院

Source(s) of funding:

Shanghai Chest Hospital, Shanghai Jiaotong University

研究疾病:

纵隔生殖细胞肿瘤  

Target disease:

Primary mediastinal germ cell tumor

研究疾病代码:

Target disease code:

研究类型:

基础科学研究

Study type:

Basic Science

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

研究纵隔恶性生殖细胞肿瘤临床、影像及病理学特点。  

Objectives of Study:

To study the clinical, radiological and pathological features of primary mediastinal germ cell tumors.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

临床信息不完整者(性别、年龄、治疗前血清学/影像学检查、治疗方式、手术信息、病理信息、术后治疗方式、预后信息不确定者)。

Exclusion criteria:

Patients with incomplete clinical histories.

研究实施时间:

Study execute time:

From 2019-11-01 00:00:00 To 2021-10-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-11-01 00:00:00 To 2019-11-30 00:00:00

干预措施:

Interventions:

组别:

精原细胞肿瘤组vs非精原细胞肿瘤

样本量:

140

Group:

seminoma group versus non-seminoma group

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市胸科医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Chest Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

患者生存

指标类型:

主要指标

Outcome:

survival

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

病理标本

组织:

Sample Name:

surgical specimen

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

未使用

Randomization Procedure (please state who generates the random number sequence and by what method):

Not used

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据由试验负责人持有,如有需要可邮件联系试验负责人

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

study leader is in charge of the primary data. please email him if the data is needed

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2019-10-20 21:59:54